Padagis Us patent expiration
1. Butoconazole Nitrate patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5993856 | PADAGIS US | Pharmaceutical preparations and methods for their administration |
Nov, 2017
(6 years ago) | |
Drugs and Companies using BUTOCONAZOLE NITRATE ingredient
Market Authorisation Date: 07 February, 1997
Treatment: Method of treating a vaginal fungal infection in a female human
Dosage: CREAM
How can I launch a generic of BUTOCONAZOLE NITRATE before it's drug patent expiration?
More Information on Dosage
BUTOCONAZOLE NITRATE family patents
2. Centany patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6013657 | PADAGIS US | Pharmaceutical compositions containing mupirocin |
Jul, 2018
(6 years ago) | |
Drugs and Companies using MUPIROCIN ingredient
Market Authorisation Date: 04 December, 2002
Treatment: NA
Dosage: OINTMENT
More Information on Dosage
CENTANY family patents
3. Clindesse patent
expiration
CLINDESSE IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5993856 | PADAGIS US | Pharmaceutical preparations and methods for their administration |
Nov, 2017
(6 years ago) | |
| US6899890 | PADAGIS US | Bioadhesive drug delivery system |
Apr, 2023
(1 year, 4 months ago) | |
| US9789057 | PADAGIS US | Pharmaceutical delivery system |
Dec, 2026
(2 years from now) | |
Drugs and Companies using CLINDAMYCIN PHOSPHATE ingredient
Market Authorisation Date: 30 November, 2004
Treatment: Method of treating bacterial vaginosis
Dosage: CREAM
How can I launch a generic of CLINDESSE before it's drug patent expiration?
More Information on Dosage
CLINDESSE family patents
4. Entocort Ec patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5643602 | PADAGIS US | Oral composition for the treatment of inflammatory bowel disease |
Jul, 2014
(10 years ago) | |
|
US5643602 (Pediatric) | PADAGIS US | Oral composition for the treatment of inflammatory bowel disease |
Jan, 2015
(9 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Apr 29, 2019 |
| M(M-178) | Apr 29, 2019 |
Drugs and Companies using BUDESONIDE ingredient
Market Authorisation Date: 02 October, 2001
Treatment: Treatment of mild to moderate active chrohn's disease involving the ileum and/or the ascending colon and the maintenance of clinical remission of mild to moderate crohn's disease involving the ileum a...
Dosage: CAPSULE, DELAYED RELEASE
How can I launch a generic of ENTOCORT EC before it's drug patent expiration?
More Information on Dosage
ENTOCORT EC family patents
5. Evamist patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6299900 | PADAGIS US | Dermal penetration enhancers and drug delivery systems involving same |
Feb, 2017
(7 years ago) | |
| US6818226 | PADAGIS US | Dermal penetration enhancers and drug delivery systems involving same |
Feb, 2017
(7 years ago) | |
| US6923983 | PADAGIS US | Transdermal delivery of hormones |
Feb, 2017
(7 years ago) | |
| US6978945 | PADAGIS US | Dispensing device |
Nov, 2021
(2 years ago) | |
Drugs and Companies using ESTRADIOL ingredient
Market Authorisation Date: 27 July, 2007
Treatment: Menopausal and postmenopausal disorders (including vasomotor symptoms associated with menopause)
Dosage: SPRAY
More Information on Dosage
EVAMIST family patents